Correspondence 0001104659-25-005699 from Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc.
Date: Jan. 23, 2025 · CIK: 0000894158 · Accession: 0001104659-25-005699
AI Filing Summary & Sentiment
File numbers found in text: 333-283722
Show Raw Text
CORRESP
1
filename1.htm
January 23, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tamika Sheppard
Re:
Theriva Biologics, Inc.
Registration Statement
on Form S-1
File No. 333-283722
Ladies and Gentlemen:
Reference is made
to our letter, filed as correspondence via EDGAR on January 21, 2025, in which we, as Sole Placement Agent for the proposed offering by
Theriva Biologics, Inc. (the “Company”), joined the Company’s request for acceleration of the effective date
of the above-referenced registration statement (the “Registration Statement”) for January 23, 2025 5:00 p.m., Eastern
Time. The Company is no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally
withdraw our request for acceleration of the effective date of the Registration Statement.
Very truly yours,
A.G.P./ALLIANCE GLOBAL PARTNERS
By:
/s/ Thomas J. Higgins
Name:
Thomas J. Higgins
Title:
Managing Director